Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract - Wikidata - wikimedia - TriplyDB

Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract

Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract

http://www.wikidata.org/entity/Q37252653

about

Alcohol and HIV Effects on the Immune System Challenges in mucosal HIV vaccine development: lessons from non-human primate models Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract Tracking the luminal exposure and lymphatic drainage pathways of intravaginal and intrarectal inocula used in nonhuman primate models of HIV transmission Antimicrobial and immune modulatory effects of lactic acid and short chain fatty acids produced by vaginal microbiota associated with eubiosis and bacterial vaginosis Barriers to HIV Cure.Factors Driving the HIV Epidemic in Southern Africa.Genital Injury Signatures and Microbiome Alterations Associated With Depot Medroxyprogesterone Acetate Usage and Intravaginal Drying Practices Transcytosis of HIV-1 through vaginal epithelial cells is dependent on trafficking to the endocytic recycling pathway.The structure of the human vaginal stratum corneum and its role in immune defense Predicting HIV-1 transmission and antibody neutralization efficacy in vivo from stoichiometric parameters.Which Antibody Functions are Important for an HIV Vaccine?The role of sex hormones and the tissue environment in immune protection against HIV in the female reproductive tract.Bacterial vaginosis and the cervicovaginal immune response.Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramide.SHIV susceptibility changes during the menstrual cycle of pigtail macaques.Mucosal immunity in the female genital tract, HIV/AIDS Vaginal microbiota and sexually transmitted infections that may influence transmission of cell-associated HIV.The barrier to HIV transmission provided by genital tract Lactobacillus colonization.Visualization of HIV-1 interactions with penile and foreskin epithelia: clues for female-to-male HIV transmission Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression.Prothymosin α variants isolated from CD8+ T cells and cervicovaginal fluid suppress HIV-1 replication through type I interferon induction.Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.The function and affinity maturation of HIV-1 gp120-specific monoclonal antibodies derived from colostral B cells HIV-1 vaginal transmission: cell-free or cell-associated virus?Molecular Signatures of Immune Activation and Epithelial Barrier Remodeling Are Enhanced during the Luteal Phase of the Menstrual Cycle: Implications for HIV Susceptibility.Animal models in HIV-1 protection and therapy Relationship of menstrual cycle and vaginal infection in female rhesus macaques challenged with repeated, low doses of SIVmac251.Visualization of X4- and R5-Tropic HIV-1 Viruses Expressing Fluorescent Proteins in Human Endometrial Cells: Application to Tropism Study.Relationship of Estimated SHIV Acquisition Time Points During the Menstrual Cycle and Thinning of Vaginal Epithelial Layers in Pigtail Macaques.Release of HIV-1 sequestered in the vesicles of oral and genital mucosal epithelial cells by epithelial-lymphocyte interaction.Short Communication: Exploring Antibody Potential as Prophylactic/Therapeutic Strategies for Prevention of Early Mucosal HIV-1 Infection.Short Communication: Virion Aggregation by Neutralizing and Nonneutralizing Antibodies to the HIV-1 Envelope Glycoprotein.Controlling the hydration rate of a hydrophilic matrix in the core of an intravaginal ring determines antiretroviral release Th17 Cells Are Preferentially Infected Very Early after Vaginal Transmission of SIV in Macaques.Early short-term treatment with neutralizing human monoclonal antibodies halts SHIV infection in infant macaques Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease.Medroxyprogesterone acetate and levonorgestrel increase genital mucosal permeability and enhance susceptibility to genital herpes simplex virus type 2 infection.Distribution of immune cells in the human cervix and implications for HIV transmission.Vaginal microbicides and their delivery platforms.

P2860

Q26773216-48F4A6F9-52C8-4E01-A109-8D1B98A9C300 Q27022152-B12B76BD-8BEE-49E1-8112-300CE12AEE3F Q27311833-27A584DF-B525-41C7-94F7-2748A06668D5 Q27313356-D9C5BEFC-5921-40AA-8D0A-98B519234162 Q28081831-C7C46831-4250-412A-A352-F9023F74D07A Q30245414-3B42024C-AC8E-4A99-8259-0B087D5113E4 Q30387557-747D779D-EBCA-4D47-868C-54B014255E16 Q33553821-E43DB463-B251-4423-873F-006527D941B6 Q33618602-E04D37C6-1FC2-4B91-8985-D32A172D336A Q33624947-725A2439-B7B4-4F5B-8BFA-E32ED817881C Q33638320-6EE4407A-1039-4DCA-B23A-53BCE9028E55 Q33772637-5951334D-A7E3-4747-B1BA-C9BEB876A8BE Q33934044-9EF0C805-80EA-4CC4-9715-2388253A60F9 Q34027489-493A9C63-6CE4-4E76-A894-EFA373FC708E Q34059103-A1029870-F6B7-47A3-8637-A7D7217C6171 Q34243579-E5B6E53F-C846-4AF4-BECF-49AB1826992F Q34275424-6B4C1194-B1D8-43AA-B1C9-4DCCD7980CDE Q35000021-62C2EBD8-B9B0-454A-A01A-6E2BFA933DAF Q35128826-917F8DA2-F6B5-404A-ACAE-85083C02E14E Q35154781-42CAFA7D-A3DC-423E-871A-5EFE9A402AB6 Q35172396-5E4A16E4-6B9C-4694-90F6-C5A60B08AD67 Q35588204-FB7F0955-8628-4D4C-B094-A33580EC2EFF Q35641451-D880F240-A86B-4A67-87C5-AA560E96154F Q35737800-B9AFF7BC-4DEF-48A5-B92A-5AE0BF33B577 Q35897398-40C5094B-2AEA-420C-A1F4-55EFD477258C Q35913894-B3975C78-B5CC-46F3-8648-475DDF213312 Q35920037-037B067B-A459-4D21-AB75-60DAF66038F8 Q36224614-1E60F2FF-E4EE-4A39-A6C6-CA807C7C6EA4 Q36242730-FDD6CA6B-A362-4573-AA47-2329DC6B683C Q36284595-456703D9-0DA8-4282-A2CE-E46D682FDA49 Q36291601-884C8967-7FA7-48F8-8D86-AEDCF67ADCAE Q36294727-C285DA03-A8CD-42C3-A47D-6F883D5633D4 Q36294806-D41643F4-0863-4669-A161-E653164E7F61 Q36666807-90A224E4-BDDC-4E13-847B-ECD0075E1C6A Q36826452-4A334D1C-1719-40CE-ADD0-51402C98A7D5 Q37171570-60853E87-BF89-4E30-9AF3-7FACA4237FC5 Q37194615-38FC27DD-8364-438C-A566-68999B30CD67 Q37280240-A49AEDBA-7879-43E4-92AE-22D8EEC05AA2 Q37619324-F4C9B950-A3F5-473C-ABCB-02ACDD3B6754 Q38186138-058D6436-EEA4-49F9-BF02-E39948E50903

P2860

Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract

http://www.wikidata.org/entity/Q37252653

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 21 August 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Defining the interaction of HI ...... the female reproductive tract

@en

Defining the interaction of HI ...... the female reproductive tract.

@nl

type

label

Defining the interaction of HI ...... the female reproductive tract

@en

Defining the interaction of HI ...... the female reproductive tract.

@nl

prefLabel

Defining the interaction of HI ...... the female reproductive tract

@en

Defining the interaction of HI ...... the female reproductive tract.

@nl

P1433

Q37252653-8B0A48AF-E706-458A-A2E8-0CC7512814AB

P1476

Q37252653-2D36E0C6-DA20-4802-963C-12984E3F9B6B

P2093

Q37252653-00CD8340-A6B9-4C03-A3F6-C7C2210AA668

Q37252653-194CB3B9-1134-490A-9116-ADF726ACCC42

Q37252653-1DD49F08-B457-4E49-8FE8-A11CAC91835F

Q37252653-22C066FC-8D5C-4BE3-97A7-FB06EBB21F6D

Q37252653-334FB1C9-8635-460B-B37C-C1BB472E6C5B

Q37252653-442FD7F7-72E7-416E-B997-CA13B611D264

Q37252653-B58D711E-4073-415E-8847-AB0B54A5315C

Q37252653-C154EF2A-DA1A-4FAD-A52F-ECDEEDC662CC

Q37252653-E7FA8B30-38C0-45DC-A54E-855CEB0D9D7F

Q37252653-FDEBD180-01EF-4FAB-8FBA-91597254872F

P2860

Q37252653-0FA879F4-59DF-48C1-A818-2F5761A274BD

Q37252653-1D41BD76-66E5-4A02-912B-7D45C3CA115B

Q37252653-242A8C40-FF11-4BB4-9BD2-DE73537A8C1C

Q37252653-2673A88D-C084-4E73-B4FE-631244983334

Q37252653-38828D6A-8016-4499-B5C3-9D45042B0ED9

Q37252653-3CEE61F4-9065-4A75-9520-4F431FBBF613

Q37252653-3D39C151-DA64-4738-8C35-5408823D0040

Q37252653-4A97A9B4-FD2F-4DBA-B692-711A8FDDF632

Q37252653-4DDB72E4-07E5-47B7-85F7-026C3F591EFF

Q37252653-4FF0716D-FE33-4962-85C7-A9B1BF084E57

P304

Q37252653-79E16386-AD72-4277-86B2-02A9F5775CF8

P31

Q37252653-3A2406E0-1FED-4FEB-9C00-763E2D436B32

P356

Q37252653-3CD9EEAA-3BDC-4784-8F57-7EC06257FB20

P407

Q37252653-6BA6E18D-859C-4D99-96FB-9BBA735CF49D

P433

Q37252653-93257CC6-D951-4379-828A-1B1538945E85

P478

Q37252653-63FD285E-3638-4F39-A8F3-E1F0BE98E96F

P50

Q37252653-906B3E38-4E4E-4233-9AB9-0DF09242DC02

P577

Q37252653-22305E1A-3D6F-4716-ACF2-AB5DE1A9AF99

P698

Q37252653-80263754-CEA8-4BEE-82A2-5FABB87FD840

P921

Q37252653-1A97B97E-7D24-4504-855D-848649C2158D

P932

Q37252653-E95412CF-15C1-4E28-AF90-6870339CA6B1

P356

P1433

Journal of Virology

P1476

Defining the interaction of HI ...... the female reproductive tract

@en

P2093

Angela J Fought

http://www.w3.org/2001/XMLSchema#string

John Lurain

http://www.w3.org/2001/XMLSchema#string

Maurice Duplantis

http://www.w3.org/2001/XMLSchema#string

Meegan Anderson

http://www.w3.org/2001/XMLSchema#string

Michael McRaven

http://www.w3.org/2001/XMLSchema#string

Nathan Vandergrift

http://www.w3.org/2001/XMLSchema#string

Nicole Galloway

http://www.w3.org/2001/XMLSchema#string

Ronald S Veazey

http://www.w3.org/2001/XMLSchema#string

Scott McCoombe

http://www.w3.org/2001/XMLSchema#string

Thomas J Hope

http://www.w3.org/2001/XMLSchema#string

P2860

Genotypic and phenotypic characterization of HIV-1 patients with primary infection

Langerin is a natural barrier to HIV-1 transmission by Langerhans cells

Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle

Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection

A photoactivatable GFP for selective photolabeling of proteins and cells

HIV binding, penetration, and primary infection in human cervicovaginal tissue

Human cervicovaginal mucus contains an activity that hinders HIV-1 movement.

Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.

Caveats associated with the use of human cervical tissue for HIV and microbicide research.

Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides.

P304

11388-11400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.01377-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-08-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23966398

http://www.w3.org/2001/XMLSchema#string

P921

P932

3807311

http://www.w3.org/2001/XMLSchema#string